Page last updated: 2024-12-08

salicylic acid glucoside

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

salicylic acid glucoside: structure given in first source; induces pathogenesis-related protein expression in tobacco; involved in systemic acquired resistance [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-(D-glucosyloxy)benzoic acid : A monosaccharide derivative that is salicylic acid in which the phenolic hydrogen is replaced by a D-glucosyl residue. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID151505
CHEBI ID87766
SCHEMBL ID4281885
MeSH IDM0225096

Synonyms (20)

Synonym
salicylic acid glucoside
3D77C27E-4425-4724-A323-C2DDF33E5E4C
salicylic acid-glucopyranoside
2-[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoic acid
10366-91-3
salicylic acid beta-glucoside
SCHEMBL4281885
2-(d-glucosyloxy)benzoic acid
o-glucosylsalicylic acid
CHEBI:87766
salicylic acid glucopyranoside
2-{[(3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}benzoic acid
2-(d-glucopyranosyloxy)benzoic acid
J-001018
2-(beta-d-glucopyranosyloxy)-benzoic acid
Q27159910
glucosylsalicylic acid
2-(hexopyranosyloxy)benzoic acid
DTXSID50908542
salicylic acid 2-o- beta -d-glucoside
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
D-glucosideAny glucoside in which the glycoside group is derived from D-glucose.
monosaccharide derivativeA carbohydrate derivative that is formally obtained from a monosaccharide.
benzoic acidsAny aromatic carboxylic acid that consists of benzene in which at least a single hydrogen has been substituted by a carboxy group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's3 (20.00)18.2507
2000's7 (46.67)29.6817
2010's4 (26.67)24.3611
2020's1 (6.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.88

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.88 (24.57)
Research Supply Index2.89 (2.92)
Research Growth Index4.69 (4.65)
Search Engine Demand Index23.70 (26.88)
Search Engine Supply Index2.33 (0.95)

This Compound (24.88)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other17 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]